Overview

Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To evaluate if utilizing Telehealth medicine for access to HIV PrEP will engage more Black and Latino Men who have sex with Men (MSM)
Phase:
Phase 4
Details
Lead Sponsor:
Vivent Health
Collaborator:
Gilead Sciences
Treatments:
Emtricitabine tenofovir alafenamide